cgmp and gmp
 
process developement
 
alt text 1
 
 
Protein production and cGMP manufacturing
Protein Production Services (PPS) is your partner for cGMP contract manufacturing services of monoclonal antibodies and other recombinant proteins for preclinical and Phase I/II clinical trials.
 
Our streamlined cGMP compliant technological platform offers a comprehensive package to our clients all the way from cloning to scale up and phase I and II  bulk API.
 
We offer technology transfer, process development, protein purification and cGMP manufacturing of recombinant proteins and plasmid DNA obtained by mammalian cell culture and microbial fermentation.

 
 
 
 
WHAT'S NEW
 
December 14, 2009
 
Protein Production Services Ltd. (PPS) announced today that the company had been awarded a second year grant from Israel's prestigious Office of the Chief Scientist (OCS) program of support for industrial R&D. The grant was designated by the OCS to partially fund the continuation of Factor VIIa process development and production program, as a part of the company's platform of "Biosimilars Plus".
more
 
September 1, 2009
 
PPS has entered into an agreement with BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, for cGMP production of BrainStorm's stem cell therapeutic product. The clinical-grade product will be used in a pre-clinical safety trial for the company’s innovative therapy for ALS.
more
 
March 10. 2009
 
Seraffix started Phase I clinical trials that will include 15 patients. A clinical batch of the protein component for the trial was prepared and released by PPS.
more
 
February 10, 2009
 
PPS Participated in a business delegation to Thistle Bioscience Showcase Event in Edinburgh, Scotland on February 3-6 2009. The mission was organized by the UK Trade & Investment as part of its ongoing programme of developing links between the UK and Israel in the life sciences sector.
more
 
January 19, 2009
 
Dr. Eli Opper, Chief Scientist of the Ministry of Industry, Trade and Labor, visited PPS and was introduced to the company's facilities and services.
more
 
April 22, 2008
 
PhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration at BIO National Venture Conference 2008. The preclinical anti-cancer and ophthalmic experiments were performed using VEGFb produced by PPS.
more